OTC: NURPF - Neuren Pharmaceuticals Limited

Yield per half year: -14.34%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Neuren Pharmaceuticals Limited

Capitalization

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.1955 0.2434 0.1681 0.1206 0.1216 0.1702 0.4408 1.07 0.3846 54.74
Выручка, млрд $
0.0012 0.0001 0.0135 0.000495 0.000717 0.0032 0.0146 0.2319 0.2132 0.2132 0.0927 212.36
Чистая прибыль, млрд $
-0.012 -0.0018 0.0031 -0.0108 -0.0092 -0.0078 0.000184 0.1571 0.142 0.142 0.0565 -272.86
EV, млрд $
0.0822 0.1483 0.0715 0.268 0.9298 2.92 1.58 1.58 1.15 85.72
EBIT, млрд $
-0.0152 -0.0063 0.0053 -0.0116 -0.0095 -0.0114 -0.0016 0.1992 0.1756 0.1756 0.0705 -279.21
EBITDA, млрд $
-0.0152 -0.0062 0.0054 -0.0116 -0.0095 -0.0114 -0.0016 0.1992 0.1756 0.1756 0.0705 -279.21
Баланс стоимость, млрд $
0.0042 0.0164 0.0247 0.0138 0.0242 0.0393 0.0416 0.2052 0.3639 0.3639 0.1348 71.96
FCF, млрд $
-0.0124 -0.0056 0.0064 -0.0117 -0.0081 -0.01 0.0036 0.1849 -0.0113 -0.0113 0.0318 6.89
Операционный денежный поток, млрд $
-0.0127 -0.0124 -0.0056 0.0064 -0.0117 -0.0081 -0.01 0.0036 0.1849 0.1849 0.0317 -273.68
Операционная прибыль, млрд $
-0.0152 -0.0063 0.0053 -0.0116 -0.0095 -0.0114 -0.0016 0.1725 0.1756 0.1756 0.0651 -279.21
Операционные расходы, млрд $
0.0152 0.0063 0.0083 0.0116 0.0095 0.0114 0.0162 0.0327 0.0377 0.0377 0.0215 31.74
CAPEX, млрд $
0.0000 0.0000 0.0000 0.0000 0 0.0000 0.0000 0.0000 0.0000 0.0000


Balance sheet

IFRS
Reporting Annual Quarterly
2004 2006 2007 2008 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0051 0.0047 0.0236 0.0138 0.0242 0.0368 0.0402 0.0171 0.0032 0.0032 0.0243 -33.28
Short Term Investments $
0.0091 0.2114 0.2191 0.2191 0.1465 188.76
Long term investments $
0.0014 0.0014 0.00
Total Receivables $
0.0000 0.0001 0.000942 0.000552 0.000755 0.0014 0.0011 0.0144 0.1576 0.1576 0.0351 191.02
Total Current Assets $
0.0061 0.0161 0.0266 0.0144 0.0249 0.04 0.0432 0.2472 0.3993 0.3993 0.1509 74.19
Чистые активы, млрд $
0.0000 0.0000 0 0.0000 0 0 0.0000 0.0000 0.0000 0.0000
Активы, млрд $
0.0062 0.0179 0.0266 0.0144 0.025 0.0401 0.0433 0.248 0.4097 0.4097 0.1532 74.95
Short Term Debt $
0.0000 0.0035 0.0000 0 0.000454 0.0020 -63.98
Задолженность, млрд $
0.002 0.0016 0.002 0.000559 0.000753 0.000803 0.0017 0.0428 0.0458 0.0458 0.0184 127.41
Чистый долг, млрд $
-0.0051 -0.0047 -0.0236 -0.0138 -0.0242 -0.0368 -0.0402 -0.0171 -0.0032 -0.0032 -0.0243 -33.28
Interest income $
0.000188 0.0000 0.000218 0.000389 0.000147 0.0000 0.000391 0.0057 0.0014 92.08
Расходы на обслуживание долга $
0.0001 0.0000 0 0 0 0.0001 0.00
Чист. проц. доходы, млрд $
0.000188 0.0000 0.000218 0.000389 0.000147 0.0000 0.000391 0.0057 0.0039 0.0014 92.08
Амортизация, млрд $
0.0001 0.0001 0.0001 0 0 0 0.0000 0.0000 0.0000 0.0000 0.0001 0.00
Себестоимость, млрд $
0.0103 0.000947 0.000707 0.000373 0 0 0 0.0000 0.0268 0.0268 0.0078 21.08
Товарно материальные запасы $
0.0000 0.0107 -0.000539 -0.000755 0 0.0144 0.0060 7.71


Share

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.0893 0.0224 0.0071 -0.0624 -0.0718 -0.0261 0.0014 1.2 1.1 1.1 0.4407 -272.61
Цена акции ао 2.53 1.08 1.71 0.96 2.79 5.45 16.98 7.57 8.14 8.14 8.19 23.88
Число акций ао, млн 149.55 165.79 90.6 102.67 117.61 128.97 128.91 130.77 129.26 129.26 127.10 1.91
FCF/акцию -0.0828 -0.0337 0.0707 -0.1143 -0.0687 -0.0774 0.0278 1.41 -0.0873 -0.0873 0.2409 4.91


Efficiency

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -287.21 -11.05 12.46 -78.11 -37.99 -19.86 0.4552 127.3 49.92 49.92 15.83 23.97 -205.61
ROA, % -193.46 -10.08 11.53 -75.08 -36.84 -19.46 0.4417 107.87 43.2 43.2 6.18 19.04 -203.24
ROS, % -2081.5 22.69 -2185.05 -1282.15 -243.79 1.26 67.72 66.61 66.61 66.61 11.68 -8.3180 -177.14
ROCE, % -38.35 21.45 -83.59 -39.39 -29.14 -3.86 97.08 48.24 48.24 48.24 16.46 32.11 -210.61
Ebit margin, % -2338.38 -1228.59 -257.52 -11.04 85.89 82.32 82.32 82.32 -3.6060 -179.60
Рентаб EBITDA, % -7134.42 39.64 -2337.58 -1328.59 -357.52 -10.97 85.9 82.33 82.33 82.33 28.64 -23.5860 -174.55
Чистая рентаб, % -1100.03 -2081.5 22.69 -2185.05 -1282.15 -243.79 1.26 67.72 66.61 66.61 11.68 -278.0700 -155.35
Operation Margin, % -7224.22 39.07 -2338.38 -1329.43 -357.77 -11.04 74.37 82.32 82.32 82.32 18.10 -25.9600 -174.54
Доходность FCF, % -6.34 -2.3 3.81 -9.72 -6.65 -5.86 0.8121 17.24 -0.8356 -212.14


Coefficients

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-16.28 -134.61 54.69 -11.15 -13.23 -21.83 5271.65 18.68 11.13 11.13 25.95 1053.28 -196.60
P/BV
46.74 14.87 6.81 8.71 5.02 4.34 23.32 14.3 4.35 4.35 3.81 10.27 -2.82
P/S
2801.85 12.41 243.73 169.58 53.23 66.65 12.65 7.42 7.42 3.25 61.91 -46.52
P/FCF
-43.54 26.23 -10.28 -15.04 -17.05 123.13 5.8 0 0 0 10.78 17.31 -189.18
E/P
-0.0074 0.0183 -0.0896 -0.0756 -0.0458 0.000417 0.1465 0 0 0 0.34 -0.0128 -210.33
EV/EBIT
-19.88 -12.59 -50.68 -578.96 14.64 8.99 8.99 8.99 -119.4040 -170.76
EV/EBITDA
23.86 -19.97 -11.7 -36.54 -582.58 14.64 8.99 8.99 13.11 -121.4380 -194.87
EV/S
466.76 155.4 130.63 63.89 12.57 7.4 7.4 7.4 3.66 44.38 -43.68
EV/FCF
-19.7 -13.78 -41.84 259.72 15.77 -139.91 -139.91 -139.91 20.06 -9.2340 27.31
Debt/EBITDA
0 0 0 0 1.94
Netdebt/Ebitda
0.7594 -4.39 1.2 2.54 3.22 25.18 -0.0858 -0.018 -0.018 -0.018 1.41 5.66 -135.44
Debt/Ratio
0 0 0 0 0.24
Debt/Equity
0 0 0.1259 0.1259 1.42 0.1259 0.00
Debt/Net Income
0 0 0 0 3.33
PEG
-11.05 -11.05 -11.0500 0.00
Бета
4.32 -3.24 2.21 2.21 -0.21 1.10 -20.02
Индекс Альтмана
15 8.91 6.38 4.1 3.96 12.45 0.9778 1.67 0.9349 0.9349 3.20 4.00 -25.08


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.41


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe